Search

everythinglearnresearchcommunity

for

Search:↓

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Targeting colon cancer stem cells might lead to better treatment results.

Scientists identified three genes important for processing certain brain chemicals, thyroid hormones, and medications.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Mutations in the WNT10A gene can cause skin, hair, teeth, and other disorders, and may also affect other areas like kidney and cancer, with potential for targeted treatments.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Stem-cell therapy shows promise for skin conditions but needs more research.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

The article explains the genetic causes and symptoms of various hair disorders and highlights the need for more research to find treatments.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Cancer development is like natural selection, involving mutated cells and environmental factors.

Bioactive molecules show promise for improving skin repair and regeneration by overcoming current challenges with further research.

New technologies help us better understand how skin microbes affect skin diseases.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Segmental Vitiligo is a stable, early-onset form of vitiligo that responds well to early treatment and is ideal for repigmentation studies.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

KFSD is a genetic disorder causing hair loss and skin issues, with no effective treatment.

Periodontal ligament stem cells show promise for regrowing tissues but require more research for safe, effective use.

The PP2A-B55α protein is essential for brain and skin development in embryos.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

PNKP is essential for keeping adult mouse progenitor cells healthy and growing normally.

Wnt and Shh signaling are key in noggin-induced tumors, and blocking them can slow tumor growth.

Skin symptoms can indicate endocrine disorders and have various treatments.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.